Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 5:13:190.
doi: 10.3389/fnins.2019.00190. eCollection 2019.

Challenge and Prospect of Traditional Chinese Medicine in Depression Treatment

Affiliations

Challenge and Prospect of Traditional Chinese Medicine in Depression Treatment

Yuan-Wei Zhang et al. Front Neurosci. .

Abstract

Current medication for depression is inadequate and far from ideal. Development of novel antidepressant drugs is a pressing task. The discovery of ketamine and related agents represents a new era in drug discovery for the rapid treatment of depression. Due to potential neurotoxicity, short-lasting efficacy, the limitation of a single target approach, and a limited role in depression prevention of these agents, additional approaches or drugs that exert synergy and compatibility, with the rapid-acting agents are required for better treatment of depression. Traditional Chinese Medicine (TCM) is a systems medicine and its clinical experience and integrated theory for diagnosis and treatment provides an alternative method of novel drug discovery in depression treatment. In TCM, there are numerous claimed effective antidepressant formulas, but comprehensive research and evidence-based clinical studies are required for their acceptance as a treatment. In this essay, we review current attempts in the discovery of new agents, TCM drug formulation, and TCM treatment of depression, and discuss the challenges and opportunities of TCM in the new era of antidepressant discovery. TCM could provide an important resource in the discovery of novel agents, assistance of the rapid-acting antidepressants, development of new agents for female patients, and the prevention of depression at its early stages. The study of depression in conjunction with TCM therefore not only provides an opportunity to scientifically evaluate the benefits and risks of TCM, but also accelerates the development of novel antidepressant agents by combining the principle of modern molecular medicine with the ideas of empirical systems medicine.

Keywords: TCM; TCM formula; antidepressant; depression; depression treatment; systems medicine.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Composition of a typical Traditional Chinese Medicine (TCM) formula. In general, there are four classes of drugs in each formula: emperor drugs, minister drugs, messenger drugs, and assistant drugs. One TCM formula contains at least one emperor drug supplemented by minister, assistant, and messenger drugs at varying numbers from zero to multiple, in order to ensure effective actions on various targets simultaneously. The empirical composite formulas have been proven to have greater efficacy and safety than single drugs in clinical practices, possibly due to their synergistic interaction and mutual detoxification (Ung et al., 2007). The composition and dosage depend on the signs or symptoms of individual patients and can be modified to fit specific individuals more accurately, in accordance with the idea of individual therapy in modern medicine. The major risk of TCM is thought to be the use if a combination of several herbs with some uncertain factors, such as toxicity, consistency of bioactive ingredients, drug-drug interaction, and so on. All of these present major challenges the development of TCM but can be managed by proper processing to minimize toxic effects, standardization of formulas by quality control to ensure a consistent level of bioactive ingredients and reproducible pharmacological actions, proper dosing and avoiding usage at the same time as other drugs, respectively.

References

    1. Abdallah C. G., Sanacora G., Duman R. S., Krystal J. H. (2015). Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu. Rev. Med. 66 509–523. 10.1146/annurev-med-053013-062946 - DOI - PMC - PubMed
    1. Ahokas A., Kaukoranta J., Wahlbeck K., Aito M. (2001). Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17 beta-estradiol: a preliminary study. J. Clin. Psychiatry 62 332–336. 10.4088/JCP.v62n0504 - DOI - PubMed
    1. Arseneault-Breard J., Rondeau I., Gilbert K., Girard S. A., Tompkins T. A., Godbout R., et al. (2012). Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms restores intestinal permeability in a rat model. Br. J. Nutr. 107 1793–1799. 10.1017/S0007114511005137 - DOI - PubMed
    1. Bangasser D. A., Valentino R. J. (2014). Sex differences in stress-related psychiatric disorders: neurobiological perspectives. Front. Neuroendocrinol. 35:303–319. 10.1016/j.yfrne.2014.03.008 - DOI - PMC - PubMed
    1. Berman R. M., Cappiello A., Anand A., Da O., Heninger G. R., Charney D. S., et al. (2000). Antidepressant effects of ketamine in depressed patients. Soc. Biol. Psychiatry 47 351–354. 10.1016/S0006-3223(99)00230-9 - DOI - PubMed

LinkOut - more resources